Knockdown of MVK does not lead to changes in NALP3 expression or activation

[1]  S. Ghavami,et al.  Airway mesenchymal cell death by mevalonate cascade inhibition: integration of autophagy, unfolded protein response and apoptosis focusing on Bcl2 family proteins. , 2014, Biochimica et biophysica acta.

[2]  M. Boes,et al.  Defects in Mitochondrial Clearance Predispose Human Monocytes to Interleukin-1β Hypersecretion , 2013, The Journal of Biological Chemistry.

[3]  L. Monasta,et al.  Mevalonate Kinase Deficiency and Neuroinflammation: Balance between Apoptosis and Pyroptosis , 2013, International journal of molecular sciences.

[4]  E. Piscianz,et al.  Lovastatin induces apoptosis through the mitochondrial pathway in an undifferentiated SH-SY5Y neuroblastoma cell line , 2013, Cell Death and Disease.

[5]  I. Dixon,et al.  Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts , 2012, Cell Death and Disease.

[6]  J. Yagüe,et al.  Clinical, Genetic, and Therapeutic Diversity in 2 Patients With Severe Mevalonate Kinase Deficiency , 2012, Pediatrics.

[7]  E. Piscianz,et al.  Defect in mevalonate pathway induces pyroptosis in Raw 264.7 murine monocytes , 2011, Apoptosis.

[8]  Frans Voorbraak,et al.  Bias in the Cq value observed with hydrolysis probe based quantitative PCR can be corrected with the estimated PCR efficiency value. , 2010, Methods.

[9]  Richard A Flavell,et al.  Innate instruction of adaptive immunity revisited: the inflammasome , 2009, EMBO molecular medicine.

[10]  A. Moorman,et al.  Amplification efficiency: linking baseline and bias in the analysis of quantitative PCR data , 2009, Nucleic acids research.

[11]  R. Steiner,et al.  Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome , 2007, Journal of Inherited Metabolic Disease.

[12]  A. Fischer,et al.  Allogeneic bone marrow transplantation in mevalonic aciduria. , 2007, The New England journal of medicine.

[13]  H. Waterham,et al.  Temperature dependence of mutant mevalonate kinase activity as a pathogenic factor in hyper-IgD and periodic fever syndrome. , 2002, Human molecular genetics.

[14]  H. Waterham,et al.  Lack of isoprenoid products raises ex vivo interleukin-1beta secretion in hyperimmunoglobulinemia D and periodic fever syndrome. , 2002, Arthritis and rheumatism.

[15]  H. Waterham,et al.  Clinical and molecular variability in childhood periodic fever with hyperimmunoglobulinaemia D. , 2001, Rheumatology.

[16]  H. Waterham,et al.  Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome , 1999, Nature Genetics.

[17]  M. Daha,et al.  Immunoglobulin D enhances the release of tumour necrosis factor‐α, and interleukin‐1β as well as interleukin‐1 receptor antagonist from human mononuclear cells , 1996, Immunology.

[18]  J. Meer,et al.  Interferon‐γ and urine neopterin in attacks of the hyperimmunoglobulinaemia D and periodic fever syndrome , 1995, European journal of clinical investigation.